Pfizer Inc. (SNSE:PFE)

Market Cap	134.92T -8.6%
Revenue (ttm)	56.37T -1.6%
Net Income	7.00T -3.2%
EPS	1,228.99 -3.4%
Shares Out	n/a
PE Ratio	19.27
Forward PE	9.20
Dividend	1,593.16 (6,113.43%)
Ex-Dividend Date	Jan 23, 2026

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	26.06
Day's Range	n/a
52-Week Range	22.18 - 27.75
Beta	0.71
RSI	0.00
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Santiago Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD